Literature DB >> 21475877

Curcumin induces caspase and calpain-dependent apoptosis in HT29 human colon cancer cells.

Nisha Singh1, Anuraag Shrivastav, Rajendra K Sharma.   

Abstract

This study aimed to elucidate the mode of action of curcumin (CCM) as an anticancer agent, and to investigate its effects on the proliferation and induction of apoptosis in HT29 human colon cancer cells. We examined the effect of CCM on two cysteine protease families, namely caspases and calpains, which are known to induce apoptosis in a number of cancer cells. We demonstrated that CCM reduces cell proliferation in HT29 cells with an IC50 value of 50±0.015 µM. Western blot analysis indicated that CCM induced apoptosis in HT29 cells by activating the expression of caspases-3 and -12, but not caspase-9. CCM also induced apoptosis in these cells through the involvement of calpain. These findings indicate that CCM-induced apoptosis in HT29 cells follows the caspase-12 apoptotic pathway, and also involves calpain.

Entities:  

Year:  2009        PMID: 21475877     DOI: 10.3892/mmr_00000148

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  Dietary Intervention for Preventing Colorectal Cancer: A Practical Guide for Physicians.

Authors:  Sang Hoon Kim; Jeong Yeon Moon; Yun Jeong Lim
Journal:  J Cancer Prev       Date:  2022-09-30

Review 2.  Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.

Authors:  Yousef H Aldebasi; Salah M Aly; Arshad H Rahmani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-12-15

3.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

4.  Synergistic Combinations of Curcumin, Sulforaphane, and Dihydrocaffeic Acid against Human Colon Cancer Cells.

Authors:  Jesús Santana-Gálvez; Javier Villela-Castrejón; Sergio O Serna-Saldívar; Luis Cisneros-Zevallos; Daniel A Jacobo-Velázquez
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

5.  Curcumin Chemoprevention Reduces the Incidence of Braf Mutant Colorectal Cancer in a Preclinical Study.

Authors:  Alexandra M Kane; Cheng Liu; Dewan T Akhter; Diane M McKeone; Craig A Bell; Kristofer J Thurecht; Barbara A Leggett; Vicki L J Whitehall
Journal:  Dig Dis Sci       Date:  2021-01-02       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.